HKPD — Cellyan Biotechnology Co., Ltd
—
Nasdaq ·
Consumer Discretionary ·
Distributors ·
CIK 2007702 ·
Hong Kong
Last close
$1.52
Market Cap
$64.29M
52W High
$29.00
52W Low
$1.34
ADV30
37,982
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | 12,844,248 | 221,841 | 3,261,125 |
| Sep 2025 | — | — | — | — | 9,633,830 | 190,912 | 4,490,399 |
| Mar 2025 | — | — | — | — | 9,417,276 | 748,721 | 4,427,507 |
Balance + Analyst (yfinance extras)
Retained Earnings
$368,089
Inventory
$360,107
Receivables
$5,228,410
ST Investments
$0
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$13,433,507
EBITDA
$-918,373
Free Cash Flow
$-6,506,908
Enterprise Value
$3,973,821
Total Cash
$221,841
Total Debt
$1,258,164
Shares Out
42,167,457
Trailing EPS
$-0.07
Book Value
$0.41
ROE
-15.6%
ROA
-5.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 13,433,507 | -1,003,439 | -1,135,963 | 12,844,248 | 3,261,125 | 9,583,123 | -751,602 |
| Mar 2025 | 20,313,818 | 200,766 | -27,056 | 9,417,276 | 4,427,507 | 4,989,769 | 569,214 |
| Mar 2024 | 16,688,364 | 1,673,248 | 1,329,717 | 8,667,228 | 4,413,569 | 4,253,659 | -394,330 |
| Mar 2023 | 12,555,991 | 1,077,074 | 998,196 | 3,406,754 | 2,821,512 | 585,242 | 1,727,079 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZYN | PTL Ltd | $59.87M | $9.75 | — |
| PTLE | PTL Ltd | $59.62M | $9.71 | — |
| DIT | AMCON DISTRIBUTING CO | $58.66M | $58.74 | — |
| MEGR | First America Resources Corp | $73.89M | $0.84 | — |
| SORA | AsiaStrategy | $55.57M | $2.23 | — |
News headlines (Yahoo Finance, 1h cache)
CELLYAN BIOTECHNOLOGY CO., LTD REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT
2026-11-16 11:40 · Yahoo
Cellyan Biotechnology Announces a 1-for-20 Reverse Stock Split
2026-10-21 12:00 · Yahoo
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period
2026-07-16 20:30 · Yahoo
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
2026-01-16 21:30 · Yahoo
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
2025-12-17 21:30 · Yahoo
One Hong Kong Pharma Digital Technology Holdings Insider Raised Their Stake In The Previous Year
2025-11-29 12:47 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.